Examkin

Question

Difficulty: MediumStudy Design

An academic medical center is organizing a retrospective cohort investigation to assess the risk of incident chronic kidney disease (CKD) associated with a newly introduced antihypertensive agent compared to standard angiotensin-converting enzyme (ACE) inhibitors. The principal investigator hypothesizes that the novel agent is highly protective against CKD in non-diabetic patients, but paradoxically accelerates renal function decline in patients with pre-existing diabetes mellitus.

To accurately test this specific hypothesis regarding the differential impact of diabetes, which of the following methodological and analytical approaches MUST be integrated into the study design? (Select all that apply)

  1. Conduct a stratified analysis that calculates the relative risk of incident chronic kidney disease separately for patients with and without diabetes.Answer
  2. Incorporate a statistical interaction term between medication type and baseline diabetes status within a multivariable regression model.Answer
  3. C
    Perform propensity score matching for diabetes status to ensure baseline equivalence before calculating a single, pooled relative risk.
  4. D
    Restrict the study population entirely to patients without baseline diabetes to eliminate its influence on the primary outcome.
  5. E
    Utilize a paired t-test to compare the mean continuous decline in estimated glomerular filtration rate between the independent novel agent and ACE inhibitor groups.

Answer

The investigators must conduct a stratified analysis calculating risks separately for diabetics and non-diabetics, and incorporate a statistical interaction term between medication type and diabetes status in their regression model.
The principal investigator is explicitly describing effect modification—where the effect of the exposure (medication) on the outcome (incident CKD) depends on a third variable (diabetes). To properly assess effect modification, investigators must use methods that allow the differing effects to be observed independently. Conducting a stratified analysis achieves this by calculating the risk separately within the diabetic and non-diabetic groups. Additionally, incorporating a statistical interaction term in a multivariable regression model provides a formal statistical test to determine if the difference in effect between the two strata is statistically significant.

Step-by-Step Solution

1
Identify the core epidemiological concept described in the principal investigator's hypothesis.
The hypothesis states that a drug has a different effect based on a third variable (diabetes status). This defines 'effect modification' (interaction), not confounding.
Recognizing the difference between confounding (a distortion to be eliminated) and effect modification (a biological reality to be described) is crucial for selecting the right study design.
2
Evaluate which methodological approaches are designed to detect and describe effect modification.
Stratified analysis (calculating effects separately for each subgroup) and interaction terms in regression models are standard methods for assessing effect modification.
These methods allow the differing effects to be observed and statistically quantified.
3
Evaluate why the other options are incorrect for this specific hypothesis.
Matching and restriction are methods used to control for confounding by eliminating the variable's influence. A paired t-test is an incorrect statistical test for independent groups.
Applying confounding control methods to an effect modifier masks the very phenomenon the study aims to investigate.

Key Concept

Effect modification occurs when the magnitude or direction of an association between an exposure and an outcome varies according to the level of a third variable. It must be evaluated using stratified analysis or interaction terms, whereas methods like matching or pooling are used to eliminate confounding.
Rate this question

Topics

Study Design

More questions from this topic